Copyright
©The Author(s) 2019.
World J Gastrointest Endosc. Nov 16, 2019; 11(11): 523-530
Published online Nov 16, 2019. doi: 10.4253/wjge.v11.i11.523
Published online Nov 16, 2019. doi: 10.4253/wjge.v11.i11.523
Figure 2 Rising Model for End-stage Liver Disease score was associated with higher probability of adverse events (P < 0.
01).
- Citation: Yoo T, Epistola R, Epistola J, Ku L, Fleischman MW, Reicher S, Eysselein VE, Hou LA. Evaluating the risk of adverse events with interventional endoscopic retrograde cholangiopancreatography and endoscopic ultrasound procedures in cirrhotic patients. World J Gastrointest Endosc 2019; 11(11): 523-530
- URL: https://www.wjgnet.com/1948-5190/full/v11/i11/523.htm
- DOI: https://dx.doi.org/10.4253/wjge.v11.i11.523